Berlin/Frankfurt—Global law firm Dentons has advised DF Deutsche Forfait AG, listed on the Frankfurt Stock Exchange, on a purchase agreement for the assets of the insolvent Ruhr-Plasma-Zentrum Bochum GmbH. The assets were acquired by the newly founded Deutsche Blutplasma HP GmbH, an indirect subsidiary of DF Deutsche Forfait. The deal is a step forward in DF Deutsche Forfait’s M&A strategy, which targets investments in the food and pharmaceutical sectors. It also represents its entrance into blood plasma collection as a new strategic business area. The transaction was completed at the beginning of May 2025.

The company plans to expand its blood plasma division through new openings or possible acquisitions in Germany or neighboring countries. The new location in Bochum will serve as a starting point.

DF Deutsche Forfait is a financial services company with business areas in foreign trade financing and M&A in the food, beverage, pharmaceutical, and healthcare sectors. The company is listed on the regulated market in the General Standard segment of the Frankfurt Stock Exchange.

A Dentons team led by Frankfurt Partner Dr. Robert Weber advised DF Deutsche Forfait on all legal issues relating to the transaction.

Advisors to DF Deutsche Forfait AG

Dentons (Berlin/Frankfurt):

Corporate/M&A: Dr. Robert Weber (Partner, lead), Hilke Schmitt (Counsel), Dr. Milan Schäfer (Associate, all Frankfurt);

Restructuring: Dr. Arne Friel (Partner), Jennifer Brenke (Counsel, both Berlin);

Data Protection: Lorenz Wascher (Counsel, Berlin)

About Dentons

Redefining possibilities. Together, everywhere. For more information visit dentons.com